EP3687627A2 - Method for epid-based verification, correction and minimisation of the isocentre of a radiotherapy device - Google Patents
Method for epid-based verification, correction and minimisation of the isocentre of a radiotherapy deviceInfo
- Publication number
- EP3687627A2 EP3687627A2 EP18814769.8A EP18814769A EP3687627A2 EP 3687627 A2 EP3687627 A2 EP 3687627A2 EP 18814769 A EP18814769 A EP 18814769A EP 3687627 A2 EP3687627 A2 EP 3687627A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- dose
- epid
- field
- measuring body
- collimator
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 77
- 238000001959 radiotherapy Methods 0.000 title claims abstract description 41
- 238000012937 correction Methods 0.000 title claims abstract description 16
- 238000012795 verification Methods 0.000 title abstract description 12
- 239000013598 vector Substances 0.000 claims abstract description 43
- 238000002560 therapeutic procedure Methods 0.000 claims description 10
- 238000012552 review Methods 0.000 claims description 4
- 238000005259 measurement Methods 0.000 abstract description 20
- 230000001419 dependent effect Effects 0.000 description 13
- 238000005457 optimization Methods 0.000 description 12
- 230000005855 radiation Effects 0.000 description 11
- 230000009466 transformation Effects 0.000 description 8
- 239000011159 matrix material Substances 0.000 description 7
- 238000006073 displacement reaction Methods 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 5
- 238000013507 mapping Methods 0.000 description 5
- 231100000987 absorbed dose Toxicity 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 4
- 229910052721 tungsten Inorganic materials 0.000 description 4
- 239000010937 tungsten Substances 0.000 description 4
- 238000004364 calculation method Methods 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 238000003384 imaging method Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 238000012935 Averaging Methods 0.000 description 2
- 241000446313 Lamella Species 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000011218 segmentation Effects 0.000 description 2
- 238000000844 transformation Methods 0.000 description 2
- GNFTZDOKVXKIBK-UHFFFAOYSA-N 3-(2-methoxyethoxy)benzohydrazide Chemical compound COCCOC1=CC=CC(C(=O)NN)=C1 GNFTZDOKVXKIBK-UHFFFAOYSA-N 0.000 description 1
- FGUUSXIOTUKUDN-IBGZPJMESA-N C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 Chemical compound C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 FGUUSXIOTUKUDN-IBGZPJMESA-N 0.000 description 1
- 239000003570 air Substances 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000037237 body shape Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000005865 ionizing radiation Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000037230 mobility Effects 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 238000002673 radiosurgery Methods 0.000 description 1
- 238000009199 stereotactic radiation therapy Methods 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N5/1048—Monitoring, verifying, controlling systems and methods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N5/1048—Monitoring, verifying, controlling systems and methods
- A61N5/1049—Monitoring, verifying, controlling systems and methods for verifying the position of the patient with respect to the radiation beam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N5/1042—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy with spatial modulation of the radiation beam within the treatment head
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N5/1048—Monitoring, verifying, controlling systems and methods
- A61N5/1075—Monitoring, verifying, controlling systems and methods for testing, calibrating, or quality assurance of the radiation treatment apparatus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N5/1077—Beam delivery systems
- A61N5/1081—Rotating beam systems with a specific mechanical construction, e.g. gantries
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N5/1048—Monitoring, verifying, controlling systems and methods
- A61N5/1049—Monitoring, verifying, controlling systems and methods for verifying the position of the patient with respect to the radiation beam
- A61N2005/1054—Monitoring, verifying, controlling systems and methods for verifying the position of the patient with respect to the radiation beam using a portal imaging system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N5/1048—Monitoring, verifying, controlling systems and methods
- A61N5/1075—Monitoring, verifying, controlling systems and methods for testing, calibrating, or quality assurance of the radiation treatment apparatus
- A61N2005/1076—Monitoring, verifying, controlling systems and methods for testing, calibrating, or quality assurance of the radiation treatment apparatus using a dummy object placed in the radiation field, e.g. phantom
Definitions
- the invention relates to a method for checking, correcting and minimizing the isocentre of a radiotherapy device, which comprises at least one patient support table rotatable about at least one table axis, a support arm rotatable about a support arm axis, a radiation head arranged on the support arm for generating a therapy beam, a rotatable collimator, a device for the projection of the radiological isocenter and a portable arm-mounted digital recording system (EPID, English: Electronic Portal Imaging
- radiotherapy devices such as electron linear accelerators, gamma knifes, cyberknifes, proton and heavy ion accelerator systems in conjunction with safety margins adapted to machine and patient positioning tolerances in the target volume definition.
- a central feature of any radiotherapy device is the spatial deviation of the central ray from the ideal punctate site, called the isocenter or ideal isocenter. In an ideal radiotherapy device, in which no mechanical tolerances occur, all angle-dependent central rays intersect in this isocenter.
- Electron linear accelerators which are used in almost every radiotherapy institution for tumor therapy, have at least three rotational degrees of freedom. These include the support arm angle with a usual value range of -180 ° to + 180 °,
- the collimator angle with a usual value range of -175 ° to + 175 ° and
- the isocenter is not a point, but an isocentroid with spatial extent (hereinafter also referred to as spatial isocenter).
- centroid is derived from ellipsoid, which is a body formed by rotation of an ellipse about one of its axes. The central rays of all combinations of the above angles intersect or touch the isocentroid.
- Isozentroids a radiotherapy device are initially the respective size and location of the individual isocentroids depending on each individual degree of freedom to determine. This measurement and verification of the isocentroids is also known as Winston-Lutz test or Winston-Lutz method.
- a radiopaque or radiation-tight measuring body which is also called the Winston-Lutz pointer and is rigidly coupled to the patient table of a radiotherapy device, is first positioned in the radiological isocenter of a radiotherapy device. This isocenter is displayed with the aid of spatially fixed, visible line lasers or projected onto the Winston-Lutz pointer.
- a flat dose image is formed with a square or round irradiation field which is limited by the block apertures of a collimator, the lamellae of a multi-leaf collimator (MLC) or by a round collimator additionally mounted on the radiator head with various support arm angles, collimator angles and table angles using a digital recording system (EPID).
- MLC multi-leaf collimator
- EPID digital recording system
- the known methods and algorithms are based, for example, on digital high-pass filters, two-dimensional operators for edge enhancement and edge finding (such as Sobel operators, Canny filters), line extraction (Hough transformation), center of mass calculation (Signal Intensity Weighting). , the convolution method, the object segmentation (segmentation, Contouring) as well as on the thresholding method.
- edge enhancement and edge finding such as Sobel operators, Canny filters
- line extraction Hough transformation
- Center of mass calculation Signal Intensity Weighting
- the convolution method the object segmentation (segmentation, Contouring) as well as on the thresholding method.
- Rowshanfarzad, P .; Sabet, M., O'Connor, DJ, Greer, PB discusses the above methods and discusses their pros and cons.
- Another disadvantage is that the positioning inaccuracies of the recording system in all EPID-based methods - in particular a violation of orthogonality to the central beam and a not exact distance to the isocenter - affect the outcome.
- Other deficiencies in the known EPID-based methods include a lack of representation of the global isocentroid, in which the central isomorphic deviation from the ideal isocenter for any combination of the three angles for the arm, collimator, and patient table is a lack of mathematical description of the global isocentroide to minimize it by optimization of parameters of the radiation therapy device as well as missing investigations of the influence of all measuring conditions on the result.
- the object underlying the present invention is now to propose an EPID-based method for checking and correcting the isocenter of a radiotherapy device, with which the disadvantages known from the prior art can be avoided or reduced.
- a method for EPID-based checking, correction and minimization of the isocenter of a radiotherapy device comprising at least one about a table axis rotatable patient table, a pivotable about a Tragarmachse support arm, arranged on the support arm radiator head for generating a therapy beam, a rotatable Collimator, comprising means for projecting the radiological isocenter and a digital acquisition system (EPID) for acquiring dose images by means of the therapy beam, proposed as follows:
- a measuring body is positioned by means of the projection device at the projection position in the current radiological isocenter of the radiotherapy device,
- an irradiation field bounded by the collimator is applied for at least one predetermined angular adjustment of the support arm, the patient support table and the collimator, and thereby
- a dose profile for each direction is created within each EPID EPID coordinate system; and e) in the course of the dose profile, at both expected body boundaries of the measurement body in the X direction of the EIPD coordinate system and at both expected body boundaries of the measuring body in the Y-direction of the EPID coordinate system between a local dose minimum and a local maximum dose and between a local maximum dose and a local dose of minismium each determined a turning point and
- a position of the center of the measuring body relative to the EPID center is determined in the dose image, wherein the steps d) to g) are carried out analogously for the field boundaries and the field center of the irradiation field, that is, it is Based on the recorded dose image, a dose profile is created and in the course of the dose profile is at both expected field boundaries of the irradiation field in the X direction of the EIPD coordinate system and at both expected field boundaries of the irradiation field in the Y direction of the EPID coordinate system between a local dose minimum and a local maximum and between a local Dosismaximum and a local Dosisminium each determined a turning point and the determined positions of the inflection points of the field boundaries of the irradiation field in the X direction and assigned in the Y direction and based on the associated field boundaries of the irradiation field in the dose image one layer of the field center of the irradiation field relative to
- a difference vector is determined from a positional deviation of the center of the measuring body from the EPID center and from a positional deviation of the center of the irradiation field from the EPID center, and i) the vector components of the difference vector are used to correct the current radiological isocenter.
- a unit change from pixel to mm can be made to determine absolute distances.
- the unit change represents a transition from the digital to the analog dose profile, so that a ter kau the geometry data can be ensured in an algorithm.
- the coordinate system which is essential for the measurement setup and for carrying out the method according to the invention is the inertial system (space-fixed radiotherapy device coordinate system), in which the isocenter deviations (central beam deviations from the ideal isocenter) are indicated.
- the inertial system has the ideal isocenter ISO (center of the measuring body or the tungsten sphere of the Winston-Lutz pointer) as the origin. Since the coordinate system of the recording device used for steps c) to h) and the collimator coordinate system are movable, coordinate transformations are required.
- the EPID coordinate system which is positioned in a support arm-proof manner and has its origin in the central detector element of the EPID.
- the projection of the current radiological isocenter is carried out by means of five space-stable line lasers.
- crosshairs which may be executed in the form of color-highlighted notches on the surface of the measuring body, the measuring body in the projected isocenter of the radiotherapy device can be accurately positioned.
- the method steps b) to h) for the angular degrees of freedom of the patient support table, the support arm and the collimator can be provided with an increment of not more than 30 °.
- differential vectors can be used to determine the size and position of the spatial isocenters are used, the vector components of the position vectors of the spatial isocenters are used to correct the radiological isocenter.
- the method according to the invention can preferably be carried out automatically, using appropriate software.
- An automatic performance of the steps d) to i) and in particular an evaluation processing of dosage profiles for finding inflection points as well as performing coordinate transformations can be carried out by means of routines, for example in the software package MATLAB ®.
- the dose profile of the dose image in the X direction and in the Y direction can be examined for inflection points between a dose minimum and a maximum dose and in the further course between a maximum dose and a minimum dose to all body boundaries of the measuring body and limits To determine the radiation field.
- the measuring body is a tungsten sphere with a diameter between 5 mm and 10 mm. It should be noted that those found in the failure mode analysis and error influence analysis
- Parameter values for suitable measurement conditions and analysis conditions are preferably valid for a ball diameter of 5 mm.
- the method according to the invention should not be limited to a spherical measuring body in order to be carried out. Therefore, other body shapes of the measuring body are also conceivable.
- the two-dimensional mapping of the diameter of a spherical measuring body and the field width of an irradiation field in the dose image corresponds to the distance between two inflection points in the dose profile parallel to the X direction of the collimator fixed diaphragm coordinate system.
- the points of inflection can be those points which have exactly 50% of the absorbed dose of the field center in the dose image. Accordingly, in the Y direction, those points can be regarded as turning points, which have exactly 50% of the absorbed dose of the field center in the dose image.
- the inflection points determined are assigned to the field boundaries of the irradiation field.
- the smallest of the local dose maxima of the dose profiles in the X direction and Y direction can be used as a replacement for the 100% dose.
- the determination of the body boundaries of the measuring body is analogous.
- the absorbed dose to define the boundaries of the spherical measuring body is the arithmetic mean of the 100% replacement dose and the local dose minimum behind the ball, ie a 50% replacement dose.
- the dose maxima are located between the spherical measuring body and the field edges, which are defined by the collimator setting.
- the inflection point (s) is / are determined in the range of a 50% dose point between a dose minimum and a maximum dose level and / or between a maximum dose level and a dose range of the dose profile.
- the definition of the field size and the central beam position with the help of the 50% -sodose is described in the standard IEC 60976.
- the measurement planes perpendicular to the image plane which cut out the corresponding dose profiles for defining the field size, the central ray and the sphere size and the sphere center, can be automatically determined by means of software using an algorithm.
- two orthogonal measurement planes can be defined in a first iteration step.
- the determined dose profiles are analyzed with respect to field size, central ray position, sphere size and center of the sphere.
- the symmetry lines of the irradiation field and of the spherical measuring body can be determined with the ascertained central beam position and the determined ball center of the measuring body.
- the lines of symmetry are identical to the lines of intersection of the measuring planes.
- a spatial resolution of 0.01 mm for the spatial deviation of the central beam can be achieved by the spherical measuring body, which can be detected by measurement.
- a process-related resolution of 0.01 mm could be achieved using an EPID with a pixel size of 0.392 mm. This can be achieved by considering a section of the inflection tangent of the dose profile in the region of the 50% dose point for the exact determination of the field boundaries or the body boundaries of the spherical measuring body.
- the turning tangent is the best approximation of the dose courses over the location coordinates.
- the least error approximation can be achieved with the shortest tangent still present in the discrete pixel size digital dose image.
- it measures exactly one pixel - or, as a special case, two pixels if the 50% dose point coincides exactly with one pixel center.
- the two pixels in the range of the 50% dose point are determined, one of which has a lower and one greater gray value than the 50% dose point.
- a specific distance can be determined.
- the exact location coordinates for the field boundaries of the radiation field and the body boundaries of the spherical measuring body can be achieved by linear interpolation between the two excellent pixels.
- the inflection point (s) in the range of the 50% dose point is / are preferably set between two pixels, of which a first pixel has a lower dose than 50% and one on the first pixel adjacent second pixel represents a larger dose than 50%.
- the difference vector is calculated as a displacement vector between the central jet piercing point and the center of the spherical measuring body, measured in the EPID plane, by means of a centric elongation in FIG the isocenter plane is mapped, where the stretch center is the beam focus and the stretch factor is
- the orientation of this inertial system is specified in the IEC 61217 standard.
- the spatial vectors of the spatial isocenters are used to calibrate a patient positioning system.
- the location vector of the isocentroids is to be understood as the spatial center position of the isocentroids.
- the advantage of the method according to the invention lies in particular in the extraction of a dose profile with the unit of length mm from a dose image with the unit of length pixels, so that this with less computational effort in a shorter time and in particular with computationally higher
- Resolution can be processed.
- a majority of the known radiation therapy devices anyway have a possibility for digital recording (EPID) of an irradiation field, so that an isocenter verification and a corresponding correction with existing devices can be carried out with little effort.
- EPID digital recording
- an Isotechniksvertechnische view of the isocenter
- a computational resolution of 0.01 mm can be achieved by the method according to the invention, without requiring any technical changes, such as high-resolution recording systems.
- a correction of machine tolerances is made.
- a correction of the position vectors in the EPID coordinate system can be provided.
- the rotation order is defined as for gimbals: angle ⁇ around the X-axis, angle ⁇ around the Y-axis and angle ⁇ around the Z-axis In its acceptance test, all angular errors are ⁇ 1 °, the rotation order has no influence on the correction, and it applies to a general angle with ⁇ in radians
- the rotation matrices are about the Y-axis and Z-axis which depend on the corresponding angular deviations ⁇ and ⁇ .
- the definition of the gimbal angles as well as the mapping matrices in equations (4) and (5) can be found, for example, in "Multibody dynamics with unilateral contacts" Pfeiffer, F., Glocker, Ch. (Wiley series in nonlinear science, series editors: Nayfeh, AH and Holden, AV, John Wiley & Sons, Inc., New York, 1996). Translational corrections do not have to be applied because the searched difference vector
- the radiation fields are limited by means of the lamellae of a multi-leaf collimator (MLC).
- MLC multi-leaf collimator
- the central beam positions between several pairs of lamellae of an MLC in the X direction are determined.
- steps d) to h) of the method according to the invention are carried out for each lamella pair of the MLC delimiting the irradiation field.
- the outer pairs of lamellae are not used for the analysis, since there the dose were disturbed by scattered photons from the aperture system to the field boundary in the Y direction.
- two dose profiles are evaluated for irradiation fields which are formed by block apertures or the MLC, which are cut out in mirror image form to the symmetry line of the X coordinate.
- the mirror-symmetric measurement planes and the arithmetic averaging of the individual central beam positions in both directions X and Y have the advantage that any angular errors of the collimator are compensated for by the averaging.
- Another advantage is that fewer field disturbances are caused by the measuring body, since the interest of interest 50% dose points of the dose profiles have a greater distance from the measuring body or the Winston-Lutz pointer.
- Support arm angle 0 ° adjusted to obtain a statement about the vertical position change of the measuring body.
- a support arm angle of 30 ° is set, whereby an angle of the patient support table in the range between 0 ° and 90 ° is made possible.
- a support arm angle of -30 ° allows an angle of the patient table in a range between 0 ° and - 90 °.
- the Isozent- roid of the table can be determined alternatively without movement of the support arm.
- Measuring element which may be a Winston-Lutz pointer from BRAINLAB AG (Feldmün, Germany), was detected radiologically in the verification step Detect Winston-Lutz Pointer with the functionality Winston-Lutz Pointer Analysis.
- the negative values of the displacements of the measuring body relative to the ideal isocenter of the radiotherapy device are vectorially stored in the file WL_Test.log. This is data in the form of a text document which can be read by the software package MATLAB ® . In the data of the file goes from columns 15-17 of the table angle-dependent displacement vector
- the displacement vector (distance vector) of the central beam from the measuring body is the vector sum
- a global isocentroid can be determined from the individual deviations in the three spatial directions X, Y and Z.
- the procedure is as follows: After for each angular degree of freedom the geometry of the isocentroide with the characteristics
- the isocentroid of the support arm is determined at 0 ° collimator and table angle.
- the isocentroid of the collimator is determined at 0 ° support arm and table angle.
- Half of the isocentroid of the table is determined with 30 ° or -30 ° support arm angle and with 0 ° collimator angle.
- the additional maximum possible isocenter deviations due to the collimator angle variation and table angle variation can be represented as scattering bands in the positive and negative directions above the support arm angle.
- the evaluation regarding the location coordinates and maximum diameter or the largest radius is finally updated.
- the center distances which are to be measured at least every six months according to DIN 6875 - Part 2, are determined between all three axes of rotation.
- the scattering bands have a negative and positive component. Its determination first requires a mapping from the EPID coordinate system to the initial coordinate system for the isocenter deviations of the collimator angle variation:
- the location vector is composed of the components of the isocenter deviation. The negative scattering bands arise too
- the interval of the collimator angle for the extreme search in equations (13) to (18) can be defined as C e [-90 °, + 90 °], since all optimal collimator angles in patient treatment are in this range.
- the scatter bands in the table angle variation are analogous to equations (13) to (18) by defining the collimator angle C through the table angle T and the extrema search intervals by T e [-90 °, + 90 °].
- T e [-90 °, + 90 °].
- Isozentroid of the support arm in the event that a round collimator and an external patient positioning system is used,
- the isocentroid of the patient support table may go unnoticed because it detects and corrects all table angle dependent central beam deviations.
- the optimization variables in the vector be summarized, where the centreline offset of the slats and y J0 is the jaw offset of the Y- pair of apertures.
- the first component of this vector may also be the jaw offset of the X-aperture pair, as long as it is intended to limit the irradiation field.
- the second component can also be identical to 0 if the field boundary in the Y direction is reached solely by the slats of the MLC.
- equation (19) includes their offsets.
- the isocentroids listed above ie the isocentroid of the support arm, the combined isocentroid of the support arm and the collimator, the combined isocentroid of the support arm and the patient table, and the global isocentroid, are functions of the support arm angle G.
- the solitary support arm isocentroid is composed of the components
- the combined Isozentroide can be described in any spatial direction by two features that they limit in the negative direction relationship ⁇ , in the positive direction:
- the collimator angle C and the table angle T of the patient support table can be varied within the specified interval.
- the value range of the collimator angle C can be limited to ⁇ 90 °, since usually all optimal collimator angles are in this range.
- a correction of machine parameters can be provided.
- the optimization can be carried out by means of software. Possible optimization functions that depend on the variables in equation (19) relate to the sums, arithmetic mean, extrema, and integrals over the squares of the squares of the squares
- equation (6) the position vector of the central ray deviations in equation (6) becomes varies in the detector coordinate system (EPID coordinate system).
- the positional deviations of the investigated isozentroids in the spatially fixed coordinate system of the radiotherapy device can be determined.
- the vector x 0 is optimal if, for one of the objective functions outlined above, which contains the variables of equation (19) in quadratic form:
- the optimized parameters in equation (19) can then be selected from the various solutions. For example, those that have the mean spatial radius can be selected
- equation for solving the non-linear optimization problem without constraints may be the subroutine fminsearch used in MATLAB ®.
- the calculation scheme used here is a simplex algorithm of the Nelder-Mead type for a direct minimum search.
- geometric tolerances of the radiotherapy device are quantified and taken into account mathematically.
- an application of the method according to the invention to a therapy simulator can be provided, the spatial isocenters being determined, corrected and minimized.
- FIG. 1 shows a two-dimensional dose image of a spherical measuring body in an MLC-limited irradiation field
- FIG. 2 a shows a dose profile of a two-dimensional dose image for explaining an embodiment of the method according to the invention
- FIG. 2b shows the dose profile from FIG. 2a for explaining the definition of FIG
- FIG. 3 is a schematic representation of the metrological proof of the achieved spatial resolution
- FIG. 4 dose profiles of the Winston-Lutz pointer as measuring body
- FIG. 5 shows further dose profiles of an MLC-limited radiation field in the X direction
- FIG. 6 shows further dose profiles of an MLC-limited radiation field in the Y direction
- FIG. 7 shows a schematic representation of the geometry of a isotope-dependent isocentroid of a radiation therapy device
- FIG. 8 shows a graphic representation of a global isocentroid.
- a radiotherapy device which at least a patient support table rotatable about at least one table axis, a support arm rotatable about a support arm axis, a radiation head for application of the therapy beam, a collimator for limiting a radiation field, a device for projecting the radiological isocenter and a digital acquisition system (EPID) for the generation of
- the method comprises the following steps: a) a measuring body 13 is positioned at the projection position of the radiological isocenter of a radiotherapy device,
- FIG. 1 is a two-dimensional gray-scale image of a dose MLC limited irradiation field size of 15 x 15 mm 2 in MATLAB ® (version R2007a).
- the EPID used has pixels with an edge length of 0.392 mm.
- the reference numeral 13 denotes a spherical measuring body (Winston-Lutz pointer) with a known diameter.
- the reference numeral 14 denotes a boundary of the irradiation field caused by the collimator. In the dose image, dark areas have a lower applied absorbed dose than bright areas.
- both ball boundaries 1 and 2 in the X direction and both ball boundaries 16 and 17 in the Y direction are determined.
- the ball boundaries 1, 2, 16 and 17 can be determined from the dose profiles which are created on the basis of the recorded dose image in step d) of the method.
- FIG. 2 a and FIG. 2 b show a dose profile 5 in the X-direction of the dose image shown in FIG.
- the curve denoted by reference numeral 6 in FIG. 2a represents the slope progression of the dose profile over the X axis.
- a center point position of the measuring body 13 is first determined by a maximum point in the course of the dose profile 5 at least one expected limit of the measuring body 13 between a dose maximum 19 and a Dosisminimum 28 a turning point 29 and between a Dosisminimum 28 and a Dosismaximum 20 a turning point 30 is determined.
- the determination of the inflection points 29 and 30 can be made in the range of the 50% dose point, wherein the 50% dose point is the position in the course of the dose profile 5, at the dose between the Dosisminimum 28 and the Dosismaxima 19 and 20 50%.
- the 50% dose point is determined between two pixels of which a first pixel represents a dose less than 50% and a second pixel adjacent the first pixel represents a dose greater than 50%.
- Analog can be proceeded to determine the field boundaries of the irradiation field, wherein in the course of the dose profile 5 at least one expected limit of the irradiation field between a dose minimum 18 and a maximum dose 19 a turning point 3 and between a dose maximum 20 and a minimum dose 21 a turning point 4 is determined ,
- the determination of inflection points 3 and 4 may be in the range of 50%
- the 50% dose point is the position in the course of the dose profile 5, in which the dose between the dose minima 18 and 21 and the Dosismaxima 19 and 20 has 50%.
- the 50% dose point is determined between two pixels of which a first pixel represents a dose less than 50% and a second pixel adjacent the first pixel represents a dose greater than 50%.
- the determined inflection points are assigned to a field boundary or a measuring body boundary.
- Direction located body boundary 1 of the measuring body 13 and the inflection point 30 of the lying in the positive X direction body boundary 2 of the measuring body 13 are assigned.
- a determination of the body boundaries of the measuring body 13 in the Y direction can be made on the basis of a dose profile in the Y direction.
- the body boundaries in the Y-direction are identified by the reference symbols 16 and 17.
- the inflection point 3 can be assigned to the field boundary located in the negative X direction and the inflection point 4 of the field boundary located in the positive X direction.
- a determination of the field boundaries in the Y direction can be based on a dose profile in the Y direction.
- the center point position of the measuring body 13 can be determined by the arithmetic mean value formation of the two spatial coordinates of the boundary points.
- the distances of the body boundaries in the X direction and in the Y direction are used for determining the midpoint position.
- the central beam position can be determined by the arithmetic mean value formation of the spatial coordinates of the boundary points.
- the distances of the field boundaries in the X direction and in the Y direction are used to determine the central beam position.
- step g) of the method the positions of the center point of the measuring body 13 and of the irradiation field relative to the EPID center are determined on the basis of the associated body boundaries of the measuring body 13 and on the basis of the associated field boundaries of the irradiation field.
- the steps d) to g) are performed for the directions X and Y.
- step h) the difference vector in the EPID plane, which points from the center of the measuring body 13 to the central jet piercing point through the EPID plane, is projected into the isocenter plane according to equation (1).
- the steps b) to h) are used for all prescribed support arm angle, collimator angle and table angle (des).
- the method according to the invention achieves a spatial resolution of 0.01 mm with a clinically standard EPID, which corresponds to a 39.2 times higher resolution than the standard EPID.
- the sizes a x and CAX X are the field width and the central beam position in the X direction, respectively. For the same irradiation field without Winston-Lutz pointer, the same values were determined for these quantities.
- the graphics were generated using MATLAB ® (version R2007a).
- FIG. 2b shows the definition of all four 50% dose points of the dose profile in the X direction of FIG. 2a, which are required for determining the measuring body boundaries, irradiation field boundaries and the positions of the measuring body center and the central beam. All 50% dose levels are defined as the arithmetic mean of a local dose minimum and a local maximum dose. The 100% dose is the smallest of all local dose maxima. The smallest possible values for the measuring body and for the irradiation field are used as dose minima. If both the respective maximum dose and the respective dose minimum for calculating the 50% dose point is minimal, its dose value also becomes minimal. Every 50% -
- Dose point is in the range of the turning point there. Both aspects increase the resolution of the method according to the invention.
- the fact that a low 50% dose point is an advantage can be explained physically as follows: The lower the 50% dose point of the field, the less disturbing the scattering photons generated in the measuring body, because the distance of the measuring body increases to the 50% dose point. And vice versa, the lower the 50% dose point of the measuring body, the less disturbing the scattering photons generated by the field boundary (slits, slats of an MLC or a circular collimator), since the distance of the field boundary from the 50% dose point increases.
- FIG. 2b shows a dose profile for the determination of the geometric properties of the irradiation field and the measuring body in the X direction.
- MK measuring body or Winston-Lutz pointer or tungsten sphere (the Winston-Lutz pointer used in the explanation of an embodiment of the method according to the invention is a commercial one of the company
- D 50 (field) 50% dose to determine the field width and field length by means of the localized tangent
- D 50% (MK) 50% replacement dose for determining the measuring body limits by means of the localized turning tangents
- D max (-X) local maximum dose of X-profile with negative local coordinate
- D max (+ X) local maximum dose of X-profile with positive local coordinate
- D max (-Y) local maximum dose of Y-profile with negative local coordinate
- D max (+ Y) local maximum dose of the Y-profile with positive location coordinate
- D min (MK) local dose minimum of both dose profiles in the area of the measuring body
- D min (-X) local dose minimum of the X-profile at the edge of the field with negative location coordinate
- D min (-Y) local dose minimum of the Y-profile at the edge of the field with negative location coordinate
- D min ( + Y) local dose minimum of the Y-profile at the edge of the field with positive location coordinate
- Xi (MK) boundary of the measuring body in the negative X direction
- X 2 (MK) boundary of the measuring body in the positive X direction
- ⁇ ( ⁇ ) position of the measuring element center in the X-direction relative to the EPID center
- ⁇ (MK) position of the center of the measuring element in the Y direction relative to the EPID
- ACAX X position of the central beam of the irradiation field in the X-direction relative to the EPID center
- ACAX Y position of the central beam of the irradiation field in the Y-direction relative to the EPID center
- ⁇ 0 central beam deviation relative to the measuring element center in the X direction (measured in the EPID plane)
- AYiso central beam deviation relative to the measuring center in the Y direction (measured in the EPID plane)
- the lamellar positions of an MLC with the smallest possible increment 0.01 mm are varied.
- the determination of the respective central beam position takes place in a large Wasserpha- ntom MP3 with a high resolution Dosimetriediode E Type 60012 as a dose detector, a two-channel electrometer TANDEM and software ME PHYSTO ® mc 2 from PTW GmbH (Freiburg, Germany).
- the focus-detector distance for detecting the spatial resolution capability is 100 cm.
- the detection of the spatial resolution is visualized. The radiological determination of the central beam deviations or from the theory
- isocenter of a radiotherapy device in the large water phantom represents the gold standard in radiotherapy.
- the black dots mark the central beam displacements determined by the Winston-Lutz method between a centrally located pair of lamellae (here No. 31) in the X direction.
- lamella pairs limiting the irradiation field were shifted in a defined manner; the smallest adjustable increment in the used
- MLC "High-Definition 120" is 0.01 mm, and the corresponding regression line has the equation
- the measurement results in the large water phantom MP3 are shown as black circles. With both measuring methods, the smallest slat shift of ⁇ 0.01 mm can be resolved.
- S o during the Winston-Lutz test, which lasted 15 minutes here, proves the relaxation of the support arm at 0 ° as a result of a positive bending moment acting on the support arm and the radiation head around the fixed X-axis.
- the black dots in the Winston-Lutz analysis no longer agree with the black circles of the
- the medium at the edge of the field and in the field is not homogeneous: air, plastic and tungsten versus homogeneous water.
- the graph in Figure 3 was generated by MATLAB ® (version R2007a).
- FIG. 4 shows dose profiles of the Winston-Lutz pointer as a measuring body in X-direction 7 and Y-direction 8 with the turning points for defining the measuring body boundaries in X-direction 9 and 10 and in Y-direction 11 and 12.
- the dashed vertical Lines 7.1 and 8.1 indicate the position of the center of the sphere in the X direction (7.1) and in the Y direction (8.1).
- the stretch factor is k -1 > 1 with the definition in equation (1).
- the graph in Figure 4 was generated using MATLAB ® (version R2007a).
- FIG. 5 shows four dose profiles of a 15 ⁇ 15 mm 2 MLC-limited irradiation field in the X-direction under the pairs of slats No. 29 to No.
- FIG. 6 shows a further two dose profiles of an MLC-limited irradiation field of the size 15 ⁇ 15 mm 2 in the Y direction between the closed plate pairs No. 27 and No. 34 with the inflection points 25 and 26 for defining the field boundaries and the positions of the local central rays in FIG Y-direction
- FIG. 7 shows a schematic illustration of the geometry of a support arm angle-dependent isocentroide of a radiation therapy device Novalis powered by TrueBeam TM STx (VARIAN Medical Systems, Inc., Palo Alto, CA, USA and BRAINLAB AG, Feldmün, Germany).
- the solid lines in the colors black, dark gray and gray represent the central beam deviations relative to the measuring body in the directions X, Y and Z of the spatially fixed coordinate system.
- the dashed lines mark the location coordinates of the isocentroids in these directions.
- the diameters in the axes of the inertial system, their maximum and the location coordinates are also output as numerical values.
- the magnitude of the spatial radius vector is shown as a function of the bracket angle (light gray line) and its
- Figure 8 shows a graphical representation of the geometry of the global Isozentroids a medical electron linac Novalis powered by True Beam TM STx using MATLAB ®.
- the solid lines in the colors black, dark gray and gray represent the contact angle dependent centroid beam deviations relative to the Winston-Lutz pointer in the directions X,
- the boundaries of the additional negative and positive scattering bands for the superimposed collimator rotation are shown as thin dash-dot lines or dashed lines, respectively. With the addition of the table angle-dependent central beam deviations, the corresponding lines are shown thick.
- the light gray line shows the angle-dependent curve of the maximum radius of the global len isozentroids.
- the dotted lines mark the location coordinates of the global isocenter.
- the diameters in the axes of the inertial system, their maxima and the location coordinates are also output as numerical values.
- the spatial distances of the axes of rotation of the collimator and table relative to the support arm rotation axis are shown in the diagram at the bottom right.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Pathology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Radiation-Therapy Devices (AREA)
Abstract
Description
Claims
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL18814769T PL3687627T3 (en) | 2017-09-27 | 2018-09-27 | Method for epid-based verification, correction and minimisation of the isocentre of a radiotherapy device |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102017009040.8A DE102017009040A1 (en) | 2017-09-27 | 2017-09-27 | Method for EPID-based verification, correction and minimization of the isocenter of a radiotherapy device |
PCT/DE2018/000275 WO2019063035A2 (en) | 2017-09-27 | 2018-09-27 | Method for epid-based verification, correction and minimisation of the isocentre of a radiotherapy device |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3687627A2 true EP3687627A2 (en) | 2020-08-05 |
EP3687627B1 EP3687627B1 (en) | 2021-12-15 |
Family
ID=64606693
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP18814769.8A Active EP3687627B1 (en) | 2017-09-27 | 2018-09-27 | Method for epid-based verification, correction and minimisation of the isocentre of a radiotherapy device |
Country Status (9)
Country | Link |
---|---|
US (1) | US11607564B2 (en) |
EP (1) | EP3687627B1 (en) |
CN (1) | CN111432878B (en) |
DE (2) | DE102017009040A1 (en) |
ES (1) | ES2909138T3 (en) |
HU (1) | HUE057803T2 (en) |
PL (1) | PL3687627T3 (en) |
PT (1) | PT3687627T (en) |
WO (1) | WO2019063035A2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11819711B2 (en) * | 2019-02-21 | 2023-11-21 | Our United Corporation | Radiotherapy system, and device and method for verifying same |
US11465000B2 (en) * | 2020-03-02 | 2022-10-11 | Elekta Instrument Ab | Treatment planning |
CN111686378B (en) * | 2020-07-14 | 2023-02-17 | 上海联影医疗科技股份有限公司 | Bed body movement precision detection method, device, equipment and storage medium |
CN111883995A (en) * | 2020-07-21 | 2020-11-03 | 杭州市中医院 | Electric transmission device for reciprocating motion of breast cancer electron beam radiotherapy field light-level finger sliding component |
CN113065203B (en) * | 2021-03-09 | 2024-04-19 | 北京工业大学 | Cylindrical surface element error model under multi-tolerance coupling effect and solving method |
CN116092632B (en) * | 2023-03-15 | 2023-06-30 | 南京谷睿生物科技有限公司 | Nuclear medicine imaging data analysis method for radiopharmaceutical evaluation |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6240162B1 (en) | 1998-01-15 | 2001-05-29 | Siemens Medical Systems, Inc. | Precision dosimetry in an intensity modulated radiation treatment system |
US6675116B1 (en) | 2000-09-22 | 2004-01-06 | Radiological Imaging Technology, Inc. | Automated calibration for radiation dosimetry using fixed or moving beams and detectors |
SE522162C2 (en) | 2002-05-06 | 2004-01-20 | Goergen Nilsson | Dose delivery quantification enabling method for radiotherapy treatment, involves analyzing measurements to obtain information about relation between measurements in phantom and information between phantom and treatment source |
US7450687B2 (en) | 2005-09-29 | 2008-11-11 | University Of Medicine And Dentistry Of New Jersey | Method for verification of intensity modulated radiation therapy |
US8130905B1 (en) | 2007-11-21 | 2012-03-06 | Sun Nuclear Corporation | Dosimetry system and method for radiation therapy |
EP2116278A1 (en) * | 2008-05-06 | 2009-11-11 | Ion Beam Applications S.A. | Device for 3D dose tracking in radiation therapy |
JP2014502541A (en) | 2010-12-22 | 2014-02-03 | ビューレイ・インコーポレイテッド | System and method for image guidance during medical procedures |
CN102921115B (en) | 2012-10-25 | 2015-04-22 | 合肥工业大学 | Method for establishing measurement data-based simple and convenient irradiation source model of medical linear accelerator |
US9283405B2 (en) * | 2013-08-02 | 2016-03-15 | The Johns Hopkins University | Method for real-time quality assurance assessment of gantry rotation and collimator rotation in radiation therapy |
US9089696B2 (en) * | 2013-11-07 | 2015-07-28 | Varian Medical Systems International Ag | Time-resolved pre-treatment portal dosimetry systems, devices, and methods |
US9604077B2 (en) | 2014-06-16 | 2017-03-28 | The Board Of Trustees Of The Leland Stanford Junior University | Visualizing radiation therapy beam in real-time in the context of patient's anatomy |
US9616251B2 (en) * | 2014-07-25 | 2017-04-11 | Varian Medical Systems, Inc. | Imaging based calibration systems, devices, and methods |
GB2539261A (en) * | 2015-06-12 | 2016-12-14 | Elekta ltd | Improvements in Dosimetry Techniques for Radiotherapy |
US9192784B1 (en) * | 2015-06-16 | 2015-11-24 | Radiological Imaging Technology, Inc. | Radiation delivery isocenter analysis tool |
CN105031833B (en) * | 2015-08-28 | 2018-02-06 | 瑞地玛医学科技有限公司 | The dosage verifying system of radiotherapy unit |
CN105204056B (en) | 2015-09-29 | 2017-11-21 | 广州瑞多思医疗科技有限公司 | Online dose monitoring and the method for checking in radiotherapy |
CN106902477B (en) * | 2017-01-23 | 2019-08-09 | 福建省肿瘤医院 | A kind of non-linear fusion method of Radiotherapy dosimetry inside and outside cervical carcinoma |
-
2017
- 2017-09-27 DE DE102017009040.8A patent/DE102017009040A1/en not_active Withdrawn
-
2018
- 2018-09-27 DE DE112018005512.4T patent/DE112018005512A5/en not_active Withdrawn
- 2018-09-27 US US16/651,254 patent/US11607564B2/en active Active
- 2018-09-27 WO PCT/DE2018/000275 patent/WO2019063035A2/en unknown
- 2018-09-27 HU HUE18814769A patent/HUE057803T2/en unknown
- 2018-09-27 PL PL18814769T patent/PL3687627T3/en unknown
- 2018-09-27 PT PT188147698T patent/PT3687627T/en unknown
- 2018-09-27 CN CN201880076345.1A patent/CN111432878B/en active Active
- 2018-09-27 EP EP18814769.8A patent/EP3687627B1/en active Active
- 2018-09-27 ES ES18814769T patent/ES2909138T3/en active Active
Also Published As
Publication number | Publication date |
---|---|
PL3687627T3 (en) | 2022-04-19 |
US20200289850A1 (en) | 2020-09-17 |
DE102017009040A1 (en) | 2019-03-28 |
WO2019063035A3 (en) | 2019-05-16 |
CN111432878A (en) | 2020-07-17 |
EP3687627B1 (en) | 2021-12-15 |
US11607564B2 (en) | 2023-03-21 |
ES2909138T3 (en) | 2022-05-05 |
CN111432878B (en) | 2022-04-15 |
WO2019063035A2 (en) | 2019-04-04 |
DE112018005512A5 (en) | 2020-08-06 |
PT3687627T (en) | 2022-03-21 |
HUE057803T2 (en) | 2022-06-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3687627B1 (en) | Method for epid-based verification, correction and minimisation of the isocentre of a radiotherapy device | |
DE102010041752B4 (en) | Calibration of a slat collimator | |
EP1623738B1 (en) | Volumetric imaging in a radiation therapy device | |
DE102015208929B3 (en) | Method for 2D-3D registration, computing device and computer program | |
DE19953177A1 (en) | Method to position patient exactly for radiation therapy or surgery; involves comparing positions in landmarks in X-ray image and reconstructed image date, to determine positioning errors | |
CN105473181A (en) | Method of calibration of a stereoscopic camera system for use with radio therapy treatment apparatus | |
DE102016221658B4 (en) | Scattered radiation compensation for a medical imaging device | |
DE102014210938A1 (en) | Method for controlling a medical device and control system for a medical device | |
EP0560331A1 (en) | Positioning device for a part of the body for therapeutic treatment | |
DE102016009676B4 (en) | Radiation treatment device and radiation treatment method | |
DE102006024242A1 (en) | X-ray system`s deviation detecting method for e.g. medical examination device, involves recording current image of actual position of measuring object by x-ray system, and comparing current image with provided reference image of object | |
DE102010020781A1 (en) | Determination and verification of the coordinate transformation between an X-ray system and a surgical navigation system | |
DE10218760A1 (en) | System and method for calibrating an image system and storage medium | |
EP1248236A2 (en) | Method and apparatus for reconstructing three dimensional images from cone-beam projection data | |
DE102019001334A1 (en) | X-RAY COMPUTER TOMOGRAPHY MEASURING DEVICE AND TOMOGRAPHIC IMAGE GENERATION PROCESS | |
EP1882232A1 (en) | Method and device for determining the material interfaces of a test object | |
WO2000033740A1 (en) | X-ray examination apparatus and method for generating distortion-free x-ray images | |
EP3569147B1 (en) | Method and device for determining a geometric calibration for an imaging device and method for determining allocation data for geometric calibration | |
DE102010027671A1 (en) | X-ray system for providing three-dimensional image of tissue of patient, has X-ray radiation sources arranged on C-shaped arm, where actual position is determined at X-ray radiation source or at X-ray detector by position sensor | |
EP3420533B1 (en) | Method for calibrating an optical measurement set-up | |
DE102013200329A1 (en) | Method and device for misalignment correction for imaging methods | |
DE112011103997T5 (en) | Method for monitoring a radiation dose | |
DE102007023925B4 (en) | Method, apparatus and arrangement for compensating the effects of focal spot migration when taking X-ray projection images | |
EP2926734A1 (en) | Method for setting up a patient irradiation device and method for positioning a patient on a patient irradiation device | |
DE102014113977A1 (en) | Method for determining at least one parameter in the dimensional measurement with a computed tomography sensor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20200414 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
INTG | Intention to grant announced |
Effective date: 20210715 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D Free format text: NOT ENGLISH Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 502018008242 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D Free format text: LANGUAGE OF EP DOCUMENT: GERMAN |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 1455026 Country of ref document: AT Kind code of ref document: T Effective date: 20220115 |
|
REG | Reference to a national code |
Ref country code: FI Ref legal event code: FGE |
|
REG | Reference to a national code |
Ref country code: PT Ref legal event code: SC4A Ref document number: 3687627 Country of ref document: PT Date of ref document: 20220321 Kind code of ref document: T Free format text: AVAILABILITY OF NATIONAL TRANSLATION Effective date: 20220315 |
|
REG | Reference to a national code |
Ref country code: SE Ref legal event code: TRGR |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: FP |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG9D |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211215 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211215 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220315 |
|
REG | Reference to a national code |
Ref country code: GR Ref legal event code: EP Ref document number: 20220400576 Country of ref document: GR Effective date: 20220418 Ref country code: ES Ref legal event code: FG2A Ref document number: 2909138 Country of ref document: ES Kind code of ref document: T3 Effective date: 20220505 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220315 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211215 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211215 |
|
REG | Reference to a national code |
Ref country code: HU Ref legal event code: AG4A Ref document number: E057803 Country of ref document: HU |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211215 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211215 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211215 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 502018008242 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220415 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211215 Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211215 |
|
26N | No opposition filed |
Effective date: 20220916 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211215 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211215 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220927 |
|
P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230530 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220927 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: TR Payment date: 20230919 Year of fee payment: 6 Ref country code: NL Payment date: 20230920 Year of fee payment: 6 Ref country code: GB Payment date: 20230921 Year of fee payment: 6 Ref country code: FI Payment date: 20230918 Year of fee payment: 6 Ref country code: CZ Payment date: 20230918 Year of fee payment: 6 Ref country code: AT Payment date: 20230915 Year of fee payment: 6 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: SK Payment date: 20230919 Year of fee payment: 6 Ref country code: SE Payment date: 20230921 Year of fee payment: 6 Ref country code: PT Payment date: 20230926 Year of fee payment: 6 Ref country code: PL Payment date: 20230919 Year of fee payment: 6 Ref country code: GR Payment date: 20230927 Year of fee payment: 6 Ref country code: FR Payment date: 20230918 Year of fee payment: 6 Ref country code: BE Payment date: 20230918 Year of fee payment: 6 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 20231019 Year of fee payment: 6 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20230929 Year of fee payment: 6 Ref country code: HU Payment date: 20231019 Year of fee payment: 6 Ref country code: DE Payment date: 20230928 Year of fee payment: 6 Ref country code: CH Payment date: 20231001 Year of fee payment: 6 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211215 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211215 |